Clinical Trials Browser

Phase 2/3 × regorafenib × 90 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT07379047 2026-04-24

GISTAR-1

Phase 2/3 Not yet recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors